Spironolactone does not reliably lower cortisol levels in humans at standard doses. While it can interfere with some of the enzymes your adrenal glands use to produce cortisol, this effect is mild and, paradoxically, your body often compensates by increasing cortisol output through other pathways. In clinical studies of women taking spironolactone for excess hair growth, baseline cortisol levels stayed the same before and after treatment.
How Spironolactone Interacts With Cortisol Production
Spironolactone is primarily a mineralocorticoid receptor blocker, meaning it opposes the hormone aldosterone. It has very low affinity for glucocorticoid receptors, which are the receptors cortisol uses to exert most of its effects. So it doesn’t directly block cortisol’s action the way it blocks aldosterone’s.
That said, spironolactone does have secondary effects on steroid-producing enzymes in the adrenal glands. In laboratory and animal studies, the drug inhibits 11β-hydroxylase and 17α-hydroxylase, two enzymes involved in the final steps of cortisol synthesis. Guinea pigs given spironolactone for three days showed reduced cortisol output from adrenal tissue. Cell-based experiments point to 17α-hydroxylase inhibition as the primary mechanism behind this reduction.
These enzymatic effects are real, but they appear to be modest in humans at typical prescribed doses (25 to 200 mg daily). The body’s feedback system, called the HPA axis, is very good at detecting even small dips in cortisol and ramping up production to compensate.
The Paradox: Cortisol May Actually Rise
Here’s where it gets counterintuitive. Mineralocorticoid receptors in the brain help regulate the body’s stress hormone system. When spironolactone blocks those receptors, the brain interprets this as a signal that hormone levels are too low, and it loosens the brakes on cortisol production.
A study in healthy humans found that spironolactone treatment significantly increased cortisol levels after a standard suppression test. Before treatment, cortisol concentrations averaged about 37 nmol/L; after spironolactone, they rose to roughly 75 nmol/L. When participants were then given a hormone that stimulates the adrenal glands, peak cortisol jumped from about 127 nmol/L to 224 nmol/L. Interestingly, ACTH levels (the pituitary hormone that tells the adrenals to make cortisol) didn’t change, suggesting the effect occurs at the adrenal level or through other regulatory signals. Short-term spironolactone use also raised nighttime cortisol levels.
In practical terms, this means spironolactone is more likely to slightly increase cortisol than to decrease it, at least in people with normal adrenal function.
What Happens to Cortisol in Women Taking It for Hormonal Symptoms
Many people searching this question take spironolactone for acne, excess facial or body hair, or polycystic ovary syndrome (PCOS). In a study of women with hirsutism, baseline cortisol, ACTH, and cortisol-binding protein levels were all normal before treatment and stayed unchanged during therapy.
Where spironolactone did show a measurable effect was on the adrenal glands’ peak cortisol response to stimulation testing. The maximum cortisol surge was reduced, and the ratio of cortisol precursors to cortisol shifted in a way consistent with mild 11β-hydroxylase inhibition. But this didn’t translate to lower resting cortisol in the bloodstream. The drug’s main hormonal benefit in these patients comes from blocking androgen receptors and reducing androgen production, not from any effect on cortisol.
Why It’s Used Alongside Cortisol-Lowering Drugs in Cushing’s
Spironolactone does show up in treatment plans for Cushing’s syndrome, a condition defined by dangerously high cortisol. But it’s not used to lower cortisol itself. Instead, it’s prescribed as a support medication to manage side effects of excess cortisol and the drugs used to treat it.
High cortisol activates mineralocorticoid receptors, causing potassium loss and high blood pressure. Spironolactone counteracts both of these problems. Consensus guidelines recommend it to correct low potassium and manage blood pressure before starting primary cortisol-lowering medications like metyrapone or osilodrostat. Some of those drugs can also cause salt retention and worsen blood pressure as a side effect, and spironolactone helps offset that too. Think of it as treating the downstream damage of high cortisol rather than attacking cortisol production directly.
Can Spironolactone Cause Adrenal Problems?
Spironolactone does not cause adrenal insufficiency (a dangerous drop in cortisol) in healthy people. However, because it blocks aldosterone’s effects, it can mimic some features of adrenal insufficiency in specific situations. There are case reports of spironolactone causing a type of electrolyte imbalance called type 4 renal tubular acidosis, where potassium rises too high because aldosterone’s action is effectively cancelled out. This is most concerning in people who already have reduced adrenal function or kidney problems, not in the general population taking the drug for blood pressure, acne, or hair loss.
If you’re taking spironolactone and concerned about cortisol, the key takeaway is that the drug’s enzymatic effects on cortisol production are too weak and too well compensated by your body’s feedback loops to produce a meaningful drop. Your resting cortisol level will almost certainly remain in the normal range. The real hormonal changes from spironolactone happen through aldosterone and androgen pathways, which is exactly why it’s prescribed.